Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 448 of 6351
-
MRNA vaccine aims to prevent shingles in older adults
Vaccine Not yet recruitingThe study will evaluate the safety, tolerability, and immunogenicity (your immune system's reaction) of 3 dose levels of the study vaccine called Herpes Zoster IN001 mRNA Vaccine (IN001) in healthy participants who are between 50 and 79 years of age.
Phase 2 • Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd • Aim: Vaccine
Last updated Jun 27, 2026 07:54 UTC
-
Could a shock drug help ARDS patients breathe easier?
Disease control Not yet recruitingAcute respiratory distress syndrome (ARDS) is a life-threatening condition with a diffuse, inflammatory form of lung injury, causing pulmonary infiltration and respiratory failure leading to poor oxygenation. It is a rapidly progressive form of respiratory failure and accounts fo…
Phase 2 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New liver dialysis machine could save lives in severe liver failure
Disease control Not yet recruitingThis study is intended to demonstrate the efficacy and safety of the DIALIVE Liver Dialysis Device when incorporated into the standard management plan for participants with A-TANGO ACLF grade 2-4. A total of 72 evaluable participants, aged 18-70, will be enrolled in up to 12 cli…
Phase 3 • Sponsor: Yaqrit Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug cocktail aims to wipe out breast cancer before surgery
Disease control Recruiting nowThis is an prospective, open label, multicenter study to evaluate the efficacy and safety of neoadjuvant Iparomlimab and Tuvonralimab (QL1706) in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer.
Phase 2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New DNA test could speed up brain infection diagnosis
Diagnosis Recruiting nowDelve Bio, Inc. is a developer of novel mNGS tests with the goal of aiding in the diagnosis of infectious diseases in several clinical indications that may not have alternative traditional diagnostic methods routinely available. A proof of concept for the clinical utility of this…
Sponsor: Delve Bio, Inc. • Aim: Diagnosis
Last updated Jul 18, 2026 00:00 UTC
-
New pill plus immunotherapy targets Hard-to-Treat cancers
Disease control Not yet recruitingThis is a single-arm, open-label, multicenter, Phase Ib/II clinical trial of CVL237 tablets in combination with serplulimab injection for the treatment of advanced solid tumors with PTEN loss or low expression
Phase 2 • Sponsor: Convalife (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a blood spin help women with failed IVF get pregnant?
Disease control Not yet recruitingEndometrial receptivity is a key determinant of success in assisted reproductive technology (ART). A significant proportion of patients experience repeated implantation failure despite euploid embryos and adequate laboratory conditions. Thin endometrium, often defined as ultrasou…
Sponsor: Azienda Sanitaria Locale di Asti • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug cocktail aims to boost stroke recovery
Disease control Not yet recruitingThis study is a multicentre, randomized, blinded-endpoint trial that aims to evaluate the efficacy and safety of human urinary kallidinogenase combined with reteplase intravenous thrombolysis in the treatment of acute ischemic stroke
Sponsor: China-Japan Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for rare kidney cancer: targeted drug plus radiation may replace chemo
Disease control Not yet recruitingThis randomized, open-label, multicenter phase II study is designed to compare disitamab vedotin plus radiotherapy with gemcitabine plus carboplatin as adjuvant treatment in patients with HER2-expressing upper tract urothelial carcinoma after radical nephroureterectomy (RNU). Eli…
Phase 2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for hard-to-treat colon cancer: combo attack with immunotherapy and radiation
Disease control Not yet recruitingThis is a randomized, parallel, open-label, multicenter exploratory clinical study designed to investigate the efficacy and safety of iparomlimab and tuvonralimab in combination with fruquintinib plus heterogeneous radiotherapy, compared with fruquintinib monotherapy, as the thir…
Phase 2 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New heart valve offers hope for patients with severe leaky heart
Disease control Not yet recruitingThe goal of this clinical trial is to assess if the TRICENTO G2 Transcatheter Valve System for Tricuspid Regurgitation (TRICENTO G2 TVSTR) is safe and efficient in treating severe tricuspid regurgitation in adult patients. The main questions it aims to answer are: * Does the tr…
Sponsor: Medira GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Magic mushroom compound tested for stubborn bipolar depression
Symptom relief Not yet recruitingThis study is a 12-week (in addition to up to 30 days of screening) randomized, double-blind, placebo-controlled, parallel-group trial. The primary objective of this study is to assess the effectiveness, safety, and tolerability of single-dose psilocybin (25 mg)-assisted therapy …
Phase 3 • Sponsor: Lakshmi N Yatham • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Could a common steroid prevent a deadly complication in AIDS patients?
Prevention Not yet recruitingThis study was a multicenter, open-label, randomized controlled clinical trial designed to evaluate the efficacy and safety of glucocorticoids in preventing paradoxical immune reconstitution inflammatory syndrome (IRIS) in patients with AIDS complicated by opportunistic infection…
Sponsor: Shanghai Public Health Clinical Center • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Arm cuff therapy may shield heart and brain after stroke
Disease control Not yet recruitingIntroduction: The management of acute myocardial injury following acute ischemic stroke (AMI-AIS), a frequent complication that severely worsens prognosis, is challenging. Remote ischemic conditioning (RIC) has demonstrated therapeutic potential in separate cardiac and cerebrovas…
Phase 3 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Sound waves could open Brain's barrier to fight deadly tumor
Disease control Not yet recruitingThis study is for people (children and adults) with a rare and aggressive brain tumor called H3K27-altered diffuse midline glioma (DMG) located in the pons, a deep part of the brainstem. These tumors are very difficult to treat because they grow into surrounding brain tissue and …
Phase 1/2 • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New combo therapy aims to improve survival in hard-to-treat rectal cancer
Disease control Recruiting nowMicrosatellite stable (MSS) locally advanced rectal cancer (LARC) remains a major therapeutic challenge despite advances in multimodal treatment. Colorectal cancer is the third most common malignancy worldwide and the second leading cause of cancer-related death. In China, rectal…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Get up and eat: a new approach to speed lung surgery recovery?
Disease control OngoingThis randomized controlled study evaluates the effects of early mobilization and early oral feeding, two components of the Enhanced Recovery After Surgery (ERAS) protocol, on postoperative outcomes in adult patients with lung cancer undergoing lobectomy at Ege University Hospital…
Sponsor: Ege University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Breathing technique may outperform spirometry for smog pneumonia recovery
Disease control Recruiting nowThe current study will be a single-blind, parallel-group randomized controlled trial involving 62 patients diagnosed with smog-induced pneumonia. The study will compare the effects of Buteyko Breathing Technique (BBT) with Incentive Spirometry (IS) on respiratory outcomes. Parti…
Sponsor: Lahore University of Biological and Applied Sciences • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a blood thinner boost vision after retinal detachment surgery?
Disease control OngoingThis interventional prospective study was conducted in the Department of Ophthalmology at Lahore General Hospital, Lahore. The study included 60 male and female patients aged 18-65 years who had rhegmatogenous retinal detachment associated with grade C proliferative vitreoretinop…
Sponsor: Lahore General Hospital • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a cell injection calm the gut after a stem cell transplant?
Disease control By invitation onlyThis study focuses on patients with gastrointestinal-dominant acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation. AmiMetosai Injection combined with corticosteroids is administered as first-line treatment. The objective is to evaluate…
Early phase 1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC